Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit - Hagens Berman

SAN FRANCISCO, Aug. 14, 2026 /PRNewswire/ -- Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to...